Phase I Study for Safety and Efficacy of P276-00 in Subjects With Myeloma

This study has been withdrawn prior to enrollment.
(Not to expose the patients to subtherapeutic dose)
Sponsor:
Information provided by:
Piramal Enterprises Limited
ClinicalTrials.gov Identifier:
NCT00547404
First received: October 19, 2007
Last updated: April 21, 2009
Last verified: April 2009
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: July 2010
  Estimated Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)